Boniva
FDA Safety Review on Bisphosphonates
By Dr. Martin McIntosh DC, DNBCE on May 13, 2010
Safety Review on Bisphosphonates: Alendronate (Fosamax, Fosamax Plus D), Etidronate (Didronel), Ibandronate (Boniva), Pamidronate (Aredia), Risedronate (Actonel, Actonel W/Calcium), Tiludronate (Skelid), and Zoledronic acid (Reclast, Zometa)
“Publications in a recent issue of The New England Journal of Medicine have raised the question about the association of atrial fibrillation with the use of bisphosphonates. FDA has [...]
Posted in Actonel, Actonel W/Calcium, Aredia, Bisphosphonates, Boniva, Didronel, FDA, fosamax, Fosamax Plus D, osteopenia drugs, osteoporosis drugs, Reclast, Skelid, Zometa | Leave a response
Severe Pain with Osteopenia & Osteoporosis Drugs – FDA Alert on Bisphosphonates
By Dr. Martin McIntosh DC, DNBCE on May 13, 2010
Warning: Severe Pain Can Occur with Osteoporosis, Osteopenia Drugs
Includes Bisphosphonates commonly used for 0steoporosis treatment including Fosamax, Fosamax Plus D, Didronel, Actonel, Actonel w/Calcium, Boniva, Aredia, Skelid, Reclast, Zometa
“FDA is alerting healthcare professionals that severe bone, joint, or muscle pain can occur in patients taking bisphosphonate drugs such as Fosamax (alendronate sodium), Actonel [...]
Posted in Actonel, Actonel W/Calcium, Aredia, Bisphosphonates, Boniva, Didronel, fosamax, Fosamax Plus D, osteoporosis drugs, Reclast, Skelid, Zometa | Tagged actonel w/calcium, aredia actonel, Bisphosphonates, bone density, Boniva, Didronel, fda warning, fosamax, Fosamax Plus D, Reclast, Skelid, Zometa | Leave a response
